Skip to content

Jason Flamm

Publications

Factors associated with suicidal ideation among people with HIV engaged in care

Authors: Satre, Derek D;Ridout, Kathryn K;Flamm, Jason;Sterling, Stacy A;Silverberg, Michael J;Silverberg, Michael J;et al.

J Affect Disord. 2024 Aug 01;358:369-376. Epub 2024-05-07.

PubMed abstract

HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial

Authors: Wohl, David A;Flamm, Jason;Mayer, Kenneth;et al.

Lancet HIV. 2024 Aug;11(8):e508-e521. Epub 2024-07-14.

PubMed abstract

Cardiovascular Disease Risk Factor Control in People With and Without Human Immunodeficiency Virus

Authors: Silverberg, Michael J;Alexeeff, Stacey E;Flamm, Jason A;Lam, Jennifer O;Sterling, Stacy A;Satre, Derek D;Satre, Derek D;et al.

Clin Infect Dis. 2024 Jan 16.

PubMed abstract

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

Authors: Lea, Alexandra N;Levine, Tory M;Davy-Mendez, Thibaut;Leibowitz, Amy;Altschuler, Andrea;Flamm, Jason;Hare, C Bradley;N Luu, Mitchell;Silverberg, Michael J;Satre, Derek D

BMC Health Serv Res. 2023 May 16;23(1):494. Epub 2023-05-16.

PubMed abstract

Racial, ethnic, and age disparities in the association of mental health symptoms and polysubstance use among persons in HIV care

Authors: Davy-Mendez, Thibaut;Flamm, Jason A;Iturralde, Esti;Silverberg, Michael J;Satre, Derek D;Satre, Derek D;et al.

PLoS One. 2023;18(11):e0294483. Epub 2023-11-28.

PubMed abstract

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL

Authors: Mitsuya Y; Winters MA; Fessel WJ; Rhee SY; Slome S; Flamm J; Horberg M; Hurley L; Klein D; Shafer RW

J Acquir Immune Defic Syndr. 2006 Sep;43(1):56-9.

PubMed abstract

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection

Authors: Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S

J Virol. 2006 Aug;80(16):8236-47.

PubMed abstract

Back To Top